Suchergebnisse

Environmental hazards do not respect international boundaries. In this volume, distinguished international researchers make a significant contribution to the understanding and management of transboundary environmental risks.The transboundary risk topics addressed highlight the key political, economic, social and cultural issues of our times, such as how transboundary risks are constructed, how they are communicated within and between countries, how the authorities can build trust in political management processes, and what forms of democratic risk management institutions are appropriate.Useful practical lessons on the management of transboundary risk at the national and international levels are drawn from the case studies. The volume provides valuable evidence and analysis for those working on international environmental issues and all aspects of risk management.

A number of guidelines for Psychosocial Risk Management in organizations have been proposed in recent decades; however, some reviews on the subject also highlights that the terms Stress and Psychosocial Risks (PRs) are not mentioned explicitly in most pieces of legislation, leading to lack of clarity on the terminology used. To improve the way of dealing with this type of vulnerability and to allow organizations to successfully manage PRs, this work proposes and characterizes a workable problem-solving method in which the PRs can be evaluated for the entropy they generate within the organization. The analysis and development of such a system is based on a series of logical formalisms for Knowledge Representation and Reasoning that are grounded on Logic Programming, complemented with an Artificial Neural Network approach to computing.

Problems of managing risks of partnership in banks taking into account the new Central Bank of Russia document "On Organization of Internal Control in Credit Organizations and Bank Groups" are considered in the article. It is pointed out that effective bank risk management including risks of partnership сan be realized only under condition of bona fide competition. Functioning of banks in competitive environment is impossible without risks, their monitoring allows to become competitive on the banking services market if various "black lists" and other unsound negative information leading to lowering the level of liquidity of a credit organization are absent. Methods of managing risks of partnership that become all the more complex under the influence of technological innovations (in particular, the development of operations with credit derivatives) are also analyzed.

This book provides a brief and general introduction to cybersecurity and cyber-risk assessment. Not limited to a specific approach or technique, its focus is highly pragmatic and is based on established international standards (including ISO 31000) as well as industrial best practices. It explains how cyber-risk assessment should be conducted, which techniques should be used when, what the typical challenges and problems are, and how they should be addressed. The content is divided into three parts. First, part I provides a conceptual introduction to the topic of risk management in general and to cybersecurity and cyber-risk management in particular. Next, part II presents the main stages of cyber-risk assessment from context establishment to risk treatment and acceptance, each illustrated by a running example. Finally, part III details four important challenges and how to reasonably deal with them in practice: risk measurement, risk scales, uncertainty, and low-frequency risks with high consequence. The target audience is mainly practitioners and students who are interested in the fundamentals and basic principles and techniques of security risk assessment, as well as lecturers seeking teaching material. The book provides an overview of the cyber-risk assessment process, the tasks involved, and how to complete them in practice.

Historically, the FDA has interpreted the requirement that a drug must be "safe" to mean that the benefits of a drug outweigh its risks. The determination was made on a "categorical" basis, where the totality of risks was weighted against the totality of benefits when considered for the purposes outlined in the drug product's labeling. If a drug did not meet this criterion, it was not approved or its label was rewritten to narrow the conditions for use. This logic was endemic in the FDA for most of the 20th century. On average, two to four drugs over each 5-year period were withdrawn from the marketplace after post-marketing surveillance data uncovered new risks. Similarly, on occasion, the FDA would require some special "tool" or intervention to improve a product's safety profile. Harm associated with medication remains the second most common type of incident in hospitals, as reported by the Clinical Excellence Commission. Health services actively review medication safety. The vast majority of medication errors result in no injury. A minor injury may result, for example, in a patient needing an increased level of monitoring. Even if incidents result in minor injury, managers and staff still take any errors very seriously, reviewing the actions around the incident and making improvements as a result. FDA's new concepts for risk management amount to a "cultural shift" in the logic of drug approval and the FDA's role. The key events that led to this change can be traced to a series of reports that highlighted the need for improved medical safety. In 1999, the IOM released a report entitled, "To Err is Human." This report reviewed the nature and cause of medication errors, estimating that up to 98,000 people died each year due to these errors. In their assessment, the IOM included both adverse drug reactions and human errors in drug administration. The report captured the attention of news reporters and the government. Headlines proclaimed alarm at the larger number of fatalities caused by medical errors. ...